mailed
on 01 Feb 2024
Last Applicant/ Owned by
10578 Science Drive, Suite 125
San Diego
CA
92121
Serial Number
97618584 filed on 04th Oct 2022
Registration Number
N/A
Correspondent Address
Aaron D. Hendelman
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Scientific research in the nature of conducting clinical trials for others in the fields of pharmaceuticals and biotechnology, namely, conducting clinical trials for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, sexual Read More
Scientific research in the nature of conducting clinical trials for others in the fields of pharmaceuticals and biotechnology, namely, conducting clinical trials for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; providing medical and scientific research information in the fields of pharmaceuticals and biotechnology; medical and scientific research, namely, conducting clinical trials for others for oligonucleotide-based therapeutics; all of the foregoing excluding medical and scientific research related to diagnostic preparations, reagents, and products
Therapeutic pharmaceuticals in the nature of oligonucleotide-conjugate based therapies, oligonucleotide-antibody conjugate based therapies, and oligonucleotide-antibody fragment conjugate based therapies for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; all of the foregoing excluding diagnostic preparations, reagents, and products
No 97618584
No Service Mark
No 45532-TM1012
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 01st Feb 2024 | FINAL REFUSAL WRITTEN |
| 01st Feb 2024 | FINAL REFUSAL E-MAILED |
| 01st Feb 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| 07th Oct 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 06th Oct 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 06th Oct 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 13th Jul 2023 | NON-FINAL ACTION WRITTEN |
| 13th Jul 2023 | NON-FINAL ACTION E-MAILED |
| 13th Jul 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 28th Jun 2023 | ASSIGNED TO EXAMINER |
